English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 151 | Tables: 154 | Medical Care
The global Neuro Monitoring Systems market was valued at US$ 3750 million in 2025 and is anticipated to reach US$ 5687 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Neuro monitoring systems are clinical equipment and software platforms used in operating rooms, neurophysiology laboratories, intensive care settings, and selected brain health assessment scenarios. Their core purpose is to acquire, display, analyze, and alert on signals from the brain, spinal cord, peripheral nerves, and related muscular responses, either continuously or intermittently, so that clinicians can identify and protect neural function during surgery, perform electroencephalography, electromyography, nerve conduction, and evoked potential testing in diagnosis, and observe brain function status and tissue oxygenation in perioperative and critical care settings. This product group typically centers on EEG, EMG, NCS, EP, IONM, and broader brain monitoring, delivered through combinations of amplifiers, stimulators, acquisition modules, dedicated software, and reporting systems. One major segment emphasizes multimodality intraoperative monitoring and surgical workflow fit, another focuses on standardized diagnostics and high quality signal acquisition in neurology laboratories, and a third extends into sedation depth, regional oximetry, long term EEG, and wireless dry electrode EEG for continuous monitoring. Major customers include tertiary hospitals, neurosurgery, spine surgery, ENT and thyroid surgery departments, neurology departments, ICUs, neurophysiology labs, and selected brain health service providers. In delivery format, the market includes standalone cart or workstation systems and portable systems. Commercial models generally combine hardware sales with software, service, training, and consumables, while competition in the high end increasingly shifts from standalone hardware capability toward multimodal integration, automated analysis, connectivity, reporting efficiency, and clinical workflow compatibility.
Neuro monitoring systems are driven by two long-term forces: surgical safety and neural function protection. As procedure volumes continue to rise in spine surgery, neurosurgery, ENT/head-and-neck, thyroid surgery, and selected vascular and orthopedic operations, hospital demand has shifted from “having monitoring” to “having a system that works well and can be standardized in routine practice.” Clinicians care less about whether a single signal can be captured and more about whether the system can support the real intraoperative workflow—nerve localization, stimulation confirmation, real-time warning, intraoperative documentation, and post-operative reporting as a closed loop—while turning experience-based operations into repeatable protocol templates that reduce training time and false judgments. As a result, competition is moving away from pure hardware specifications toward a combined capability set: multimodality support, workflow fit, alarm strategy design, interference resistance, and robust data retention. At the same time, compliance and hospital IT requirements are rising. Electrical safety, EMC, data interfaces, report formats, and integration with hospital information systems can materially affect procurement decisions and installation speed. Overall, intraoperative neuromonitoring remains the clearest, most mature, and highest-willingness-to-pay submarket, serving as the stable base for industry expansion. From a product and commercialization perspective, the market is evolving toward “diagnostic integration + continuous monitoring + software-and-service enablement.” On the diagnostic side, neurophysiology systems (EMG, NCS, EP, EEG, etc.) are consolidating into multimodal platforms, as hospitals aim to cover more exam types with fewer devices while improving throughput via preset protocols, automated analysis, and standardized reporting—reducing reliance on a small number of highly experienced technologists. On the monitoring side, growing perioperative and ICU needs are pushing continuous EEG, anesthesia depth assessment, and brain oxygenation-related monitoring from specialist labs toward bedside monitoring ecosystems, which supports growth in platform-based systems and modular deployments. More importantly, revenue models are shifting toward a “hardware + software + services + consumables” mix. Beyond device sales, software licensing and upgrades, maintenance and training, accessories and electrode consumables, and value-added modules around reporting and data management strengthen customer stickiness and lifetime value. For vendors, the ability to deliver a stable clinical workflow, continuously improved software experience, and dependable service coverage determines whether they can transition from one-time device suppliers to long-term solution providers—and how high their margins and competitive barriers can be. In terms of industry structure and the next two years of trends, the market shows a dual pattern: high-end platforms remain concentrated among established US/EU/Japanese players, while Asian local supply is accelerating. Mature vendors retain advantages in multimodal platforms, clinical evidence, regulatory readiness, and channel depth, making them more likely to hold share in top-tier hospitals and complex procedures. Meanwhile, Chinese vendors benefit from localized delivery, cost performance, and fast service response, enabling stronger penetration in replacement cycles and new installations—especially in routine diagnostics, entry-level intraoperative monitoring, and regional hospital coverage. Korean companies are more aggressive in lightweight directions such as wireless devices, dry electrodes, and cloud-enabled analytics, expanding the boundary into “rapid screening, remote assessment, and brain health management.” This creates incremental use cases and user groups, but also introduces more complex challenges in compliance, clinical evidence, and reimbursement. Looking ahead, growth will come from three drivers: higher penetration as nerve protection requirements rise in high-risk surgeries; upgrade demand driven by replacement cycles and multimodal platform integration; and recurring revenue enabled by automation, data management, and service layers. In the near term, competition will center on a combined capability triad: clinical usability, workflow standardization, and compliant delivery execution.
This report delivers a comprehensive overview of the global Neuro Monitoring Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neuro Monitoring Systems. The Neuro Monitoring Systems market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neuro Monitoring Systems market comprehensively. Regional market sizes by Type, by Application, by Signal, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neuro Monitoring Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medtronic
Inomed Medizintechnik
Inmed Equipments
Nihon Kohden
Dr. Langer Medical
NeuroWave Systems
Natus (Nicolet)
Cadwell
Neurosoft
Neurovision Medical Products
Philips
Masimo
LAXTHA
iMediSync
NCC Medical
DEYMED
EB Neuro
Compumedics
Fukuda Denshi
Ybrain
Megnosis
Haishen (Suzhou) Medical Instruments Co., Ltd.
Contec Medical Systems Co., Ltd.
Humaneotec Health Industry (Guangdong) Co., Ltd.
Jiangsu BNYC Medical Technology Co., Ltd.
Segment by Type
Sub-Sensory Evoked Potentials
Brainstem Auditory Evoked Potentials
Visual Evoked Potentials
Somatosensory-Evoked Potentials
Segment by Signal
EMG
EP
EEG
rSO2
Segment by Form
Standalone Console
Bedside Monitor Platform Module
Hybrid
Segment by Application
Hospitals
Diagnostic Labs
Ambulatory Surgical Centers
Outpatient Clinics
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Signal, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Neuro Monitoring Systems companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuro Monitoring Systems Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Sub-Sensory Evoked Potentials
1.2.3 Brainstem Auditory Evoked Potentials
1.2.4 Visual Evoked Potentials
1.2.5 Somatosensory-Evoked Potentials
1.3 Market by Signal
1.3.1 Global Neuro Monitoring Systems Market Size Growth Rate by Signal: 2021 vs 2025 vs 2032
1.3.2 EMG
1.3.3 EP
1.3.4 EEG
1.3.5 rSO2
1.4 Market by Form
1.4.1 Global Neuro Monitoring Systems Market Size Growth Rate by Form: 2021 vs 2025 vs 2032
1.4.2 Standalone Console
1.4.3 Bedside Monitor Platform Module
1.4.4 Hybrid
1.5 Market by Application
1.5.1 Global Neuro Monitoring Systems Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospitals
1.5.3 Diagnostic Labs
1.5.4 Ambulatory Surgical Centers
1.5.5 Outpatient Clinics
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Neuro Monitoring Systems Market Perspective (2021–2032)
2.2 Global Neuro Monitoring Systems Growth Trends by Region
2.2.1 Global Neuro Monitoring Systems Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Neuro Monitoring Systems Historic Market Size by Region (2021–2026)
2.2.3 Neuro Monitoring Systems Forecasted Market Size by Region (2027–2032)
2.3 Neuro Monitoring Systems Market Dynamics
2.3.1 Neuro Monitoring Systems Industry Trends
2.3.2 Neuro Monitoring Systems Market Drivers
2.3.3 Neuro Monitoring Systems Market Challenges
2.3.4 Neuro Monitoring Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuro Monitoring Systems Players by Revenue
3.1.1 Global Top Neuro Monitoring Systems Players by Revenue (2021–2026)
3.1.2 Global Neuro Monitoring Systems Revenue Market Share by Players (2021–2026)
3.2 Global Top Neuro Monitoring Systems Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Neuro Monitoring Systems Revenue
3.4 Global Neuro Monitoring Systems Market Concentration Ratio
3.4.1 Global Neuro Monitoring Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuro Monitoring Systems Revenue in 2025
3.5 Global Key Players of Neuro Monitoring Systems Head Offices and Areas Served
3.6 Global Key Players of Neuro Monitoring Systems, Products and Applications
3.7 Global Key Players of Neuro Monitoring Systems, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Neuro Monitoring Systems Breakdown Data by Type
4.1 Global Neuro Monitoring Systems Historic Market Size by Type (2021–2026)
4.2 Global Neuro Monitoring Systems Forecasted Market Size by Type (2027–2032)
5 Neuro Monitoring Systems Breakdown Data by Application
5.1 Global Neuro Monitoring Systems Historic Market Size by Application (2021–2026)
5.2 Global Neuro Monitoring Systems Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Neuro Monitoring Systems Market Size (2021–2032)
6.2 North America Neuro Monitoring Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Neuro Monitoring Systems Market Size by Country (2021–2026)
6.4 North America Neuro Monitoring Systems Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuro Monitoring Systems Market Size (2021–2032)
7.2 Europe Neuro Monitoring Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Neuro Monitoring Systems Market Size by Country (2021–2026)
7.4 Europe Neuro Monitoring Systems Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Neuro Monitoring Systems Market Size (2021–2032)
8.2 Asia-Pacific Neuro Monitoring Systems Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Neuro Monitoring Systems Market Size by Region (2021–2026)
8.4 Asia-Pacific Neuro Monitoring Systems Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Neuro Monitoring Systems Market Size (2021–2032)
9.2 Latin America Neuro Monitoring Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Neuro Monitoring Systems Market Size by Country (2021–2026)
9.4 Latin America Neuro Monitoring Systems Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuro Monitoring Systems Market Size (2021–2032)
10.2 Middle East & Africa Neuro Monitoring Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Neuro Monitoring Systems Market Size by Country (2021–2026)
10.4 Middle East & Africa Neuro Monitoring Systems Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neuro Monitoring Systems Introduction
11.1.4 Medtronic Revenue in Neuro Monitoring Systems Business (2021–2026)
11.1.5 Medtronic Recent Development
11.2 Inomed Medizintechnik
11.2.1 Inomed Medizintechnik Company Details
11.2.2 Inomed Medizintechnik Business Overview
11.2.3 Inomed Medizintechnik Neuro Monitoring Systems Introduction
11.2.4 Inomed Medizintechnik Revenue in Neuro Monitoring Systems Business (2021–2026)
11.2.5 Inomed Medizintechnik Recent Development
11.3 Inmed Equipments
11.3.1 Inmed Equipments Company Details
11.3.2 Inmed Equipments Business Overview
11.3.3 Inmed Equipments Neuro Monitoring Systems Introduction
11.3.4 Inmed Equipments Revenue in Neuro Monitoring Systems Business (2021–2026)
11.3.5 Inmed Equipments Recent Development
11.4 Nihon Kohden
11.4.1 Nihon Kohden Company Details
11.4.2 Nihon Kohden Business Overview
11.4.3 Nihon Kohden Neuro Monitoring Systems Introduction
11.4.4 Nihon Kohden Revenue in Neuro Monitoring Systems Business (2021–2026)
11.4.5 Nihon Kohden Recent Development
11.5 Dr. Langer Medical
11.5.1 Dr. Langer Medical Company Details
11.5.2 Dr. Langer Medical Business Overview
11.5.3 Dr. Langer Medical Neuro Monitoring Systems Introduction
11.5.4 Dr. Langer Medical Revenue in Neuro Monitoring Systems Business (2021–2026)
11.5.5 Dr. Langer Medical Recent Development
11.6 NeuroWave Systems
11.6.1 NeuroWave Systems Company Details
11.6.2 NeuroWave Systems Business Overview
11.6.3 NeuroWave Systems Neuro Monitoring Systems Introduction
11.6.4 NeuroWave Systems Revenue in Neuro Monitoring Systems Business (2021–2026)
11.6.5 NeuroWave Systems Recent Development
11.7 Natus (Nicolet)
11.7.1 Natus (Nicolet) Company Details
11.7.2 Natus (Nicolet) Business Overview
11.7.3 Natus (Nicolet) Neuro Monitoring Systems Introduction
11.7.4 Natus (Nicolet) Revenue in Neuro Monitoring Systems Business (2021–2026)
11.7.5 Natus (Nicolet) Recent Development
11.8 Cadwell
11.8.1 Cadwell Company Details
11.8.2 Cadwell Business Overview
11.8.3 Cadwell Neuro Monitoring Systems Introduction
11.8.4 Cadwell Revenue in Neuro Monitoring Systems Business (2021–2026)
11.8.5 Cadwell Recent Development
11.9 Neurosoft
11.9.1 Neurosoft Company Details
11.9.2 Neurosoft Business Overview
11.9.3 Neurosoft Neuro Monitoring Systems Introduction
11.9.4 Neurosoft Revenue in Neuro Monitoring Systems Business (2021–2026)
11.9.5 Neurosoft Recent Development
11.10 Neurovision Medical Products
11.10.1 Neurovision Medical Products Company Details
11.10.2 Neurovision Medical Products Business Overview
11.10.3 Neurovision Medical Products Neuro Monitoring Systems Introduction
11.10.4 Neurovision Medical Products Revenue in Neuro Monitoring Systems Business (2021–2026)
11.10.5 Neurovision Medical Products Recent Development
11.11 Philips
11.11.1 Philips Company Details
11.11.2 Philips Business Overview
11.11.3 Philips Neuro Monitoring Systems Introduction
11.11.4 Philips Revenue in Neuro Monitoring Systems Business (2021–2026)
11.11.5 Philips Recent Development
11.12 Masimo
11.12.1 Masimo Company Details
11.12.2 Masimo Business Overview
11.12.3 Masimo Neuro Monitoring Systems Introduction
11.12.4 Masimo Revenue in Neuro Monitoring Systems Business (2021–2026)
11.12.5 Masimo Recent Development
11.13 LAXTHA
11.13.1 LAXTHA Company Details
11.13.2 LAXTHA Business Overview
11.13.3 LAXTHA Neuro Monitoring Systems Introduction
11.13.4 LAXTHA Revenue in Neuro Monitoring Systems Business (2021–2026)
11.13.5 LAXTHA Recent Development
11.14 iMediSync
11.14.1 iMediSync Company Details
11.14.2 iMediSync Business Overview
11.14.3 iMediSync Neuro Monitoring Systems Introduction
11.14.4 iMediSync Revenue in Neuro Monitoring Systems Business (2021–2026)
11.14.5 iMediSync Recent Development
11.15 NCC Medical
11.15.1 NCC Medical Company Details
11.15.2 NCC Medical Business Overview
11.15.3 NCC Medical Neuro Monitoring Systems Introduction
11.15.4 NCC Medical Revenue in Neuro Monitoring Systems Business (2021–2026)
11.15.5 NCC Medical Recent Development
11.16 DEYMED
11.16.1 DEYMED Company Details
11.16.2 DEYMED Business Overview
11.16.3 DEYMED Neuro Monitoring Systems Introduction
11.16.4 DEYMED Revenue in Neuro Monitoring Systems Business (2021–2026)
11.16.5 DEYMED Recent Development
11.17 EB Neuro
11.17.1 EB Neuro Company Details
11.17.2 EB Neuro Business Overview
11.17.3 EB Neuro Neuro Monitoring Systems Introduction
11.17.4 EB Neuro Revenue in Neuro Monitoring Systems Business (2021–2026)
11.17.5 EB Neuro Recent Development
11.18 Compumedics
11.18.1 Compumedics Company Details
11.18.2 Compumedics Business Overview
11.18.3 Compumedics Neuro Monitoring Systems Introduction
11.18.4 Compumedics Revenue in Neuro Monitoring Systems Business (2021–2026)
11.18.5 Compumedics Recent Development
11.19 Fukuda Denshi
11.19.1 Fukuda Denshi Company Details
11.19.2 Fukuda Denshi Business Overview
11.19.3 Fukuda Denshi Neuro Monitoring Systems Introduction
11.19.4 Fukuda Denshi Revenue in Neuro Monitoring Systems Business (2021–2026)
11.19.5 Fukuda Denshi Recent Development
11.20 Ybrain
11.20.1 Ybrain Company Details
11.20.2 Ybrain Business Overview
11.20.3 Ybrain Neuro Monitoring Systems Introduction
11.20.4 Ybrain Revenue in Neuro Monitoring Systems Business (2021–2026)
11.20.5 Ybrain Recent Development
11.21 Megnosis
11.21.1 Megnosis Company Details
11.21.2 Megnosis Business Overview
11.21.3 Megnosis Neuro Monitoring Systems Introduction
11.21.4 Megnosis Revenue in Neuro Monitoring Systems Business (2021–2026)
11.21.5 Megnosis Recent Development
11.22 Haishen (Suzhou) Medical Instruments Co., Ltd.
11.22.1 Haishen (Suzhou) Medical Instruments Co., Ltd. Company Details
11.22.2 Haishen (Suzhou) Medical Instruments Co., Ltd. Business Overview
11.22.3 Haishen (Suzhou) Medical Instruments Co., Ltd. Neuro Monitoring Systems Introduction
11.22.4 Haishen (Suzhou) Medical Instruments Co., Ltd. Revenue in Neuro Monitoring Systems Business (2021–2026)
11.22.5 Haishen (Suzhou) Medical Instruments Co., Ltd. Recent Development
11.23 Contec Medical Systems Co., Ltd.
11.23.1 Contec Medical Systems Co., Ltd. Company Details
11.23.2 Contec Medical Systems Co., Ltd. Business Overview
11.23.3 Contec Medical Systems Co., Ltd. Neuro Monitoring Systems Introduction
11.23.4 Contec Medical Systems Co., Ltd. Revenue in Neuro Monitoring Systems Business (2021–2026)
11.23.5 Contec Medical Systems Co., Ltd. Recent Development
11.24 Humaneotec Health Industry (Guangdong) Co., Ltd.
11.24.1 Humaneotec Health Industry (Guangdong) Co., Ltd. Company Details
11.24.2 Humaneotec Health Industry (Guangdong) Co., Ltd. Business Overview
11.24.3 Humaneotec Health Industry (Guangdong) Co., Ltd. Neuro Monitoring Systems Introduction
11.24.4 Humaneotec Health Industry (Guangdong) Co., Ltd. Revenue in Neuro Monitoring Systems Business (2021–2026)
11.24.5 Humaneotec Health Industry (Guangdong) Co., Ltd. Recent Development
11.25 Jiangsu BNYC Medical Technology Co., Ltd.
11.25.1 Jiangsu BNYC Medical Technology Co., Ltd. Company Details
11.25.2 Jiangsu BNYC Medical Technology Co., Ltd. Business Overview
11.25.3 Jiangsu BNYC Medical Technology Co., Ltd. Neuro Monitoring Systems Introduction
11.25.4 Jiangsu BNYC Medical Technology Co., Ltd. Revenue in Neuro Monitoring Systems Business (2021–2026)
11.25.5 Jiangsu BNYC Medical Technology Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuro Monitoring Systems Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Sub-Sensory Evoked Potentials
Table 3. Key Players of Brainstem Auditory Evoked Potentials
Table 4. Key Players of Visual Evoked Potentials
Table 5. Key Players of Somatosensory-Evoked Potentials
Table 6. Global Neuro Monitoring Systems Market Size Growth Rate by Signal (US$ Million): 2021 vs 2025 vs 2032
Table 7. Key Players of EMG
Table 8. Key Players of EP
Table 9. Key Players of EEG
Table 10. Key Players of rSO2
Table 11. Global Neuro Monitoring Systems Market Size Growth Rate by Form (US$ Million): 2021 vs 2025 vs 2032
Table 12. Key Players of Standalone Console
Table 13. Key Players of Bedside Monitor Platform Module
Table 14. Key Players of Hybrid
Table 15. Global Neuro Monitoring Systems Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 16. Global Neuro Monitoring Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Neuro Monitoring Systems Market Size by Region (US$ Million), 2021–2026
Table 18. Global Neuro Monitoring Systems Market Share by Region (2021–2026)
Table 19. Global Neuro Monitoring Systems Forecasted Market Size by Region (US$ Million), 2027–2032
Table 20. Global Neuro Monitoring Systems Market Share by Region (2027–2032)
Table 21. Neuro Monitoring Systems Market Trends
Table 22. Neuro Monitoring Systems Market Drivers
Table 23. Neuro Monitoring Systems Market Challenges
Table 24. Neuro Monitoring Systems Market Restraints
Table 25. Global Neuro Monitoring Systems Revenue by Players (US$ Million), 2021–2026
Table 26. Global Neuro Monitoring Systems Market Share by Players (2021–2026)
Table 27. Global Top Neuro Monitoring Systems Players by Tier (Tier 1, Tier 2, and Tier 3), based on Neuro Monitoring Systems Revenue, 2025
Table 28. Ranking of Global Top Neuro Monitoring Systems Companies by Revenue (US$ Million) in 2025
Table 29. Global 5 Largest Players Market Share by Neuro Monitoring Systems Revenue (CR5 and HHI), 2021–2026
Table 30. Global Key Players of Neuro Monitoring Systems, Headquarters and Area Served
Table 31. Global Key Players of Neuro Monitoring Systems, Products and Applications
Table 32. Global Key Players of Neuro Monitoring Systems, Date of General Availability (GA)
Table 33. Mergers and Acquisitions, Expansion Plans
Table 34. Global Neuro Monitoring Systems Market Size by Type (US$ Million), 2021–2026
Table 35. Global Neuro Monitoring Systems Revenue Market Share by Type (2021–2026)
Table 36. Global Neuro Monitoring Systems Forecasted Market Size by Type (US$ Million), 2027–2032
Table 37. Global Neuro Monitoring Systems Revenue Market Share by Type (2027–2032)
Table 38. Global Neuro Monitoring Systems Market Size by Application (US$ Million), 2021–2026
Table 39. Global Neuro Monitoring Systems Revenue Market Share by Application (2021–2026)
Table 40. Global Neuro Monitoring Systems Forecasted Market Size by Application (US$ Million), 2027–2032
Table 41. Global Neuro Monitoring Systems Revenue Market Share by Application (2027–2032)
Table 42. North America Neuro Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. North America Neuro Monitoring Systems Market Size by Country (US$ Million), 2021–2026
Table 44. North America Neuro Monitoring Systems Market Size by Country (US$ Million), 2027–2032
Table 45. Europe Neuro Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Europe Neuro Monitoring Systems Market Size by Country (US$ Million), 2021–2026
Table 47. Europe Neuro Monitoring Systems Market Size by Country (US$ Million), 2027–2032
Table 48. Asia-Pacific Neuro Monitoring Systems Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 49. Asia-Pacific Neuro Monitoring Systems Market Size by Region (US$ Million), 2021–2026
Table 50. Asia-Pacific Neuro Monitoring Systems Market Size by Region (US$ Million), 2027–2032
Table 51. Latin America Neuro Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Latin America Neuro Monitoring Systems Market Size by Country (US$ Million), 2021–2026
Table 53. Latin America Neuro Monitoring Systems Market Size by Country (US$ Million), 2027–2032
Table 54. Middle East & Africa Neuro Monitoring Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Middle East & Africa Neuro Monitoring Systems Market Size by Country (US$ Million), 2021–2026
Table 56. Middle East & Africa Neuro Monitoring Systems Market Size by Country (US$ Million), 2027–2032
Table 57. Medtronic Company Details
Table 58. Medtronic Business Overview
Table 59. Medtronic Neuro Monitoring Systems Product
Table 60. Medtronic Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 61. Medtronic Recent Development
Table 62. Inomed Medizintechnik Company Details
Table 63. Inomed Medizintechnik Business Overview
Table 64. Inomed Medizintechnik Neuro Monitoring Systems Product
Table 65. Inomed Medizintechnik Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 66. Inomed Medizintechnik Recent Development
Table 67. Inmed Equipments Company Details
Table 68. Inmed Equipments Business Overview
Table 69. Inmed Equipments Neuro Monitoring Systems Product
Table 70. Inmed Equipments Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 71. Inmed Equipments Recent Development
Table 72. Nihon Kohden Company Details
Table 73. Nihon Kohden Business Overview
Table 74. Nihon Kohden Neuro Monitoring Systems Product
Table 75. Nihon Kohden Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 76. Nihon Kohden Recent Development
Table 77. Dr. Langer Medical Company Details
Table 78. Dr. Langer Medical Business Overview
Table 79. Dr. Langer Medical Neuro Monitoring Systems Product
Table 80. Dr. Langer Medical Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 81. Dr. Langer Medical Recent Development
Table 82. NeuroWave Systems Company Details
Table 83. NeuroWave Systems Business Overview
Table 84. NeuroWave Systems Neuro Monitoring Systems Product
Table 85. NeuroWave Systems Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 86. NeuroWave Systems Recent Development
Table 87. Natus (Nicolet) Company Details
Table 88. Natus (Nicolet) Business Overview
Table 89. Natus (Nicolet) Neuro Monitoring Systems Product
Table 90. Natus (Nicolet) Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 91. Natus (Nicolet) Recent Development
Table 92. Cadwell Company Details
Table 93. Cadwell Business Overview
Table 94. Cadwell Neuro Monitoring Systems Product
Table 95. Cadwell Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 96. Cadwell Recent Development
Table 97. Neurosoft Company Details
Table 98. Neurosoft Business Overview
Table 99. Neurosoft Neuro Monitoring Systems Product
Table 100. Neurosoft Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 101. Neurosoft Recent Development
Table 102. Neurovision Medical Products Company Details
Table 103. Neurovision Medical Products Business Overview
Table 104. Neurovision Medical Products Neuro Monitoring Systems Product
Table 105. Neurovision Medical Products Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 106. Neurovision Medical Products Recent Development
Table 107. Philips Company Details
Table 108. Philips Business Overview
Table 109. Philips Neuro Monitoring Systems Product
Table 110. Philips Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 111. Philips Recent Development
Table 112. Masimo Company Details
Table 113. Masimo Business Overview
Table 114. Masimo Neuro Monitoring Systems Product
Table 115. Masimo Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 116. Masimo Recent Development
Table 117. LAXTHA Company Details
Table 118. LAXTHA Business Overview
Table 119. LAXTHA Neuro Monitoring Systems Product
Table 120. LAXTHA Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 121. LAXTHA Recent Development
Table 122. iMediSync Company Details
Table 123. iMediSync Business Overview
Table 124. iMediSync Neuro Monitoring Systems Product
Table 125. iMediSync Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 126. iMediSync Recent Development
Table 127. NCC Medical Company Details
Table 128. NCC Medical Business Overview
Table 129. NCC Medical Neuro Monitoring Systems Product
Table 130. NCC Medical Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 131. NCC Medical Recent Development
Table 132. DEYMED Company Details
Table 133. DEYMED Business Overview
Table 134. DEYMED Neuro Monitoring Systems Product
Table 135. DEYMED Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 136. DEYMED Recent Development
Table 137. EB Neuro Company Details
Table 138. EB Neuro Business Overview
Table 139. EB Neuro Neuro Monitoring Systems Product
Table 140. EB Neuro Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 141. EB Neuro Recent Development
Table 142. Compumedics Company Details
Table 143. Compumedics Business Overview
Table 144. Compumedics Neuro Monitoring Systems Product
Table 145. Compumedics Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 146. Compumedics Recent Development
Table 147. Fukuda Denshi Company Details
Table 148. Fukuda Denshi Business Overview
Table 149. Fukuda Denshi Neuro Monitoring Systems Product
Table 150. Fukuda Denshi Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 151. Fukuda Denshi Recent Development
Table 152. Ybrain Company Details
Table 153. Ybrain Business Overview
Table 154. Ybrain Neuro Monitoring Systems Product
Table 155. Ybrain Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 156. Ybrain Recent Development
Table 157. Megnosis Company Details
Table 158. Megnosis Business Overview
Table 159. Megnosis Neuro Monitoring Systems Product
Table 160. Megnosis Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 161. Megnosis Recent Development
Table 162. Haishen (Suzhou) Medical Instruments Co., Ltd. Company Details
Table 163. Haishen (Suzhou) Medical Instruments Co., Ltd. Business Overview
Table 164. Haishen (Suzhou) Medical Instruments Co., Ltd. Neuro Monitoring Systems Product
Table 165. Haishen (Suzhou) Medical Instruments Co., Ltd. Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 166. Haishen (Suzhou) Medical Instruments Co., Ltd. Recent Development
Table 167. Contec Medical Systems Co., Ltd. Company Details
Table 168. Contec Medical Systems Co., Ltd. Business Overview
Table 169. Contec Medical Systems Co., Ltd. Neuro Monitoring Systems Product
Table 170. Contec Medical Systems Co., Ltd. Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 171. Contec Medical Systems Co., Ltd. Recent Development
Table 172. Humaneotec Health Industry (Guangdong) Co., Ltd. Company Details
Table 173. Humaneotec Health Industry (Guangdong) Co., Ltd. Business Overview
Table 174. Humaneotec Health Industry (Guangdong) Co., Ltd. Neuro Monitoring Systems Product
Table 175. Humaneotec Health Industry (Guangdong) Co., Ltd. Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 176. Humaneotec Health Industry (Guangdong) Co., Ltd. Recent Development
Table 177. Jiangsu BNYC Medical Technology Co., Ltd. Company Details
Table 178. Jiangsu BNYC Medical Technology Co., Ltd. Business Overview
Table 179. Jiangsu BNYC Medical Technology Co., Ltd. Neuro Monitoring Systems Product
Table 180. Jiangsu BNYC Medical Technology Co., Ltd. Revenue in Neuro Monitoring Systems Business (US$ Million), 2021–2026
Table 181. Jiangsu BNYC Medical Technology Co., Ltd. Recent Development
Table 182. Research Programs/Design for This Report
Table 183. Key Data Information from Secondary Sources
Table 184. Key Data Information from Primary Sources
Table 185. Authors List of This Report
List of Figures
Figure 1. Neuro Monitoring Systems Picture
Figure 2. Global Neuro Monitoring Systems Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Neuro Monitoring Systems Market Share by Type: 2025 vs 2032
Figure 4. Sub-Sensory Evoked Potentials Features
Figure 5. Brainstem Auditory Evoked Potentials Features
Figure 6. Visual Evoked Potentials Features
Figure 7. Somatosensory-Evoked Potentials Features
Figure 8. Global Neuro Monitoring Systems Market Size Comparison by Signal (US$ Million), 2021–2032
Figure 9. EMG Features
Figure 10. EP Features
Figure 11. EEG Features
Figure 12. rSO2 Features
Figure 13. Global Neuro Monitoring Systems Market Size Comparison by Form (US$ Million), 2021–2032
Figure 14. Standalone Console Features
Figure 15. Bedside Monitor Platform Module Features
Figure 16. Hybrid Features
Figure 17. Global Neuro Monitoring Systems Market Size by Application (US$ Million), 2021–2032
Figure 18. Global Neuro Monitoring Systems Market Share by Application: 2025 vs 2032
Figure 19. Hospitals Case Studies
Figure 20. Diagnostic Labs Case Studies
Figure 21. Ambulatory Surgical Centers Case Studies
Figure 22. Outpatient Clinics Case Studies
Figure 23. Neuro Monitoring Systems Report Years Considered
Figure 24. Global Neuro Monitoring Systems Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 25. Global Neuro Monitoring Systems Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Neuro Monitoring Systems Market Share by Region: 2025 vs 2032
Figure 27. Global Neuro Monitoring Systems Market Share by Players in 2025
Figure 28. Global Neuro Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. The Top 10 and 5 Players Market Share by Neuro Monitoring Systems Revenue in 2025
Figure 30. North America Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. North America Neuro Monitoring Systems Market Share by Country (2021–2032)
Figure 32. United States Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Canada Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Neuro Monitoring Systems Market Share by Country (2021–2032)
Figure 36. Germany Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. France Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. U.K. Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Italy Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Russia Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Ireland Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Neuro Monitoring Systems Market Share by Region (2021–2032)
Figure 44. China Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Japan Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. South Korea Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Southeast Asia Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. India Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Australia & New Zealand Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Neuro Monitoring Systems Market Share by Country (2021–2032)
Figure 52. Mexico Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Brazil Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Neuro Monitoring Systems Market Share by Country (2021–2032)
Figure 56. Israel Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Saudi Arabia Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. UAE Neuro Monitoring Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. Medtronic Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 60. Inomed Medizintechnik Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 61. Inmed Equipments Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 62. Nihon Kohden Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 63. Dr. Langer Medical Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 64. NeuroWave Systems Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 65. Natus (Nicolet) Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 66. Cadwell Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 67. Neurosoft Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 68. Neurovision Medical Products Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 69. Philips Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 70. Masimo Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 71. LAXTHA Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 72. iMediSync Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 73. NCC Medical Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 74. DEYMED Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 75. EB Neuro Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 76. Compumedics Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 77. Fukuda Denshi Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 78. Ybrain Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 79. Megnosis Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 80. Haishen (Suzhou) Medical Instruments Co., Ltd. Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 81. Contec Medical Systems Co., Ltd. Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 82. Humaneotec Health Industry (Guangdong) Co., Ltd. Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 83. Jiangsu BNYC Medical Technology Co., Ltd. Revenue Growth Rate in Neuro Monitoring Systems Business (2021–2026)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
